HitGen, Inc. Hits Day Low at CNY 28.00 Amid Price Pressure

HitGen, Inc., a prominent player in the Pharmaceuticals & Biotechnology sector, experienced a notable decline of 4.72% on July 28, 2026, marking a challenging day for the stock. During intraday trading, HitGen touched a low of CNY 28.00, reflecting the stock's volatility in the current market environment. Despite this recent downturn, HitGen has shown resilience over the longer term, with a year-to-date performance of 20.51%, significantly outperforming the China Shanghai Composite, which has seen a decline of 3.92% in the same period. Over the past year, the stock has generated returns of 24.06%, again surpassing the broader market index. Key financial metrics indicate a strong operational foundation, with a remarkable net profit growth of 114.98% reported in September. The company also achieved its highest operating cash flow at CNY 204.8 million and a return on capital employed (ROCE) of 8.01%. These indicators suggest that while the stock faces short-term pressures, HitGen maintains a solid financial position within its industry.